9 results
10-K
2021 FY
SYBE
SYBLEU Inc
24 Sep 21
Annual report
7:54am
the definitive assessment of how effective the product is in comparison with current best standard treatment and to provide an adequate basis for physician … Commission, or COSO. Based on its assessment, management believes that, as of June 30,2021 the Company’s internal control over financial reporting
424B3
SYBE
SYBLEU Inc
21 Oct 20
Prospectus supplement
1:03pm
from the requirement to obtain an attestation and report from our auditors on the assessment of our internal control over financial reporting pursuant … trials are performed on larger groups.
Phase III trials are aimed at being the definitive assessment of how effective the product is in comparison
S-1/A
2kupdaxljn
21 Sep 20
IPO registration (amended)
9:45am
S-1
8kr2a jo5s7t
17 Aug 20
IPO registration
1:33pm
- Prev
- 1
- Next